Xi'an International Medical Investment Company Limited (SHE:000516)
China flag China · Delayed Price · Currency is CNY
4.170
-0.010 (-0.24%)
Aug 26, 2026, 3:04 PM CST

SHE:000516 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
-264.48-313.08-254.13-368.36-1,177-822.17
Depreciation & Amortization
643.64672.15730.54769.89620.31568.64
Other Amortization
23.453314.6113.9412.978.77
Loss (Gain) From Sale of Assets
-0.17-0.18-1.66-1.95-7.250.17
Asset Writedown & Restructuring Costs
5.460.252.590.873.361.9
Loss (Gain) From Sale of Investments
-8.09-27.98-23.77-73.8663.3365.3
Provision & Write-off of Bad Debts
-0-7.635.7515.556.935.93
Other Operating Activities
63.0720.8964.67122.7181.67166.51
Change in Accounts Receivable
164.67177.74-133.05-285.53142.34-44.09
Change in Inventory
-0.8413.78-2.67-9.110.63-26.63
Change in Accounts Payable
538.31695.04589.74867.72511.94486.85
Change in Other Net Operating Assets
--6.6632.8137.08135.89
Operating Cash Flow
1,1771,2761,0091,087461.34456.34
Operating Cash Flow Growth
9.41%26.49%-7.19%135.69%1.10%1004.15%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-155.58-262.47-547.74-762.67-1,188-1,660
Sale of Property, Plant & Equipment
34.234.190.5-97.240.48
Divestitures
----160-
Investment in Securities
0.6587.923921.3689417.66
Other Investing Activities
16.8913.242.06-20.6823.6241.98
Investing Cash Flow
-103.84-127.11-506.19-762-817.99-1,200

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Issued
-493.01717.48796.76802.791,175
Long-Term Debt Repaid
--1,593-1,372-1,061-565.18-914.98
Net Debt Issued (Repaid)
-1,046-1,100-654.68-264.22237.61259.73
Issuance of Common Stock
13.42---32.551,201
Repurchase of Common Stock
--42.6-57.44--3.94-
Common Dividends Paid
-131.36-149.21-183.72-217.4-245.42-232.34
Other Financing Activities
-20.78-16.78-2.5-83.52-75.01
Financing Cash Flow
-1,185-1,309-898.33-565.1520.81,304

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Cash Flow
-111.04-159.43-395.4-239.82-335.85560.15

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
1,0221,014461.38324.66-726.51-1,203
Free Cash Flow Growth
48.70%119.78%42.11%---
Free Cash Flow Margin
25.09%24.89%9.58%7.03%-26.80%-41.20%
Free Cash Flow Per Share
0.460.450.200.14-0.32-0.54
Levered Free Cash Flow
291.46288.5-440.9-494.17-1,406-931.78
Unlevered Free Cash Flow
331.05374.68-332.55-357.27-1,287-812.55

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
80.8972.2979.3472.34-159.63-170.39
Change in Working Capital
714.53899.05470.51608.56756.7461.29